Trials / Completed
CompletedNCT01711840
Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy
Symbicort Turbuhaler 30/60 Clinical Experience Investigation for Treatment With Symbicort as Maintenance Therapy and as Needed in Response to Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,409 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of the investigation is to confirm the safety of patients receiving Symbicort Turbuhaler as maintenance and reliever therapy ( Symbicort SMART) under the post-marketing actual use.
Detailed description
Symbicort Turbuhaler 30/60 Clinical Experience Investigation for treatment with Symbicort as maintenance therapy and as needed in response to symptoms
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2012-10-22
- Last updated
- 2016-07-18
Locations
47 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01711840. Inclusion in this directory is not an endorsement.